fabrazyme.com - ERT Treatment for Fabry Disease | Fabrazyme® (agalsidase beta)

home > domains > fabrazyme.com

Description: Fabrazyme® (agalsidase beta) is a proven treatment for patients with Fabry disease with a 20+ year commitment to the Fabry community. Learn more.

Example domain paragraphs

FOR U.S. RESIDENTS ONLY

The only ERT indicated for patients 2 years of age and older that has proven long-term efficacy and safety.

INDICATION AND USAGE

Links to fabrazyme.com (2)

• lysosomaltreatmentcenter.com Support
• avalideavapro.com Exploring Our Prescription Product Information | Sanofi USA